FDA PMA FDA Class 3 Approved 🇺🇸 United States

Drug-Eluting Peripheral Transluminal Angioplasty Catheter

PMA: P190019 · Supplement: S031 · Decision Dec 11, 2024
Classifications
1
FEI Numbers
26
Registration Numbers
26

Basic Information

Device Name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Trade Name
Ranger™ Paclitaxel-Coated PTA Balloon Catheter
PMA Number
P190019
Supplement Number
S031
Device Class
FDA Class 3
Product Code
ONU
Generic Name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
December 11, 2024
Date Received
May 17, 2024
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Labeling Change - PAS
Expedited Review
N

Advisory Committee Statement

Approval for modified labeling for the Ranger Paclitaxel-Coated PTA Balloon Catheter to reflect the long-term data from the Post-Approval Study

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
ONU Drug-Eluting Peripheral Transluminal Angioplasty Catheter